Increased soluble thrombomodulin in hemodialysis patients with long-term erythropoietin treatment: what does it reflect?

Clin Appl Thromb Hemost. 2003 Oct;9(4):349-52. doi: 10.1177/107602960300900413.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Biomarkers / blood
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / pathology
  • Erythropoietin / therapeutic use*
  • Humans
  • Renal Dialysis*
  • Thrombomodulin / blood*

Substances

  • Biomarkers
  • Thrombomodulin
  • Erythropoietin